Charity invests £1 million to develop a treatment to slow down progression of Parkinson's

(Parkinson's UK) Charity Parkinson's UK is partnering with NRG Therapeutics Ltd to discover and develop a potential drug that could safeguard dopamine cells that are damaged by Parkinson's and slow down the progression of the condition.

from EurekAlert! - Social and Behavioral Science https://ift.tt/2XkMmOF